A detailed history of Soros Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Soros Capital Management LLC holds 51,700 shares of EXAS stock, worth $3.07 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
51,700
Holding current value
$3.07 Million
% of portfolio
0.98%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $2.19 Million - $3.66 Million
51,700 New
51,700 $3.52 Million
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $2.88 Million - $4.01 Million
-39,790 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $2.91 Million - $4.33 Million
31,058 Added 355.68%
39,790 $4.95 Million
Q1 2021

May 10, 2021

BUY
$116.57 - $155.01 $1.02 Million - $1.35 Million
8,732 New
8,732 $1.15 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Soros Capital Management LLC Portfolio

Follow Soros Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Capital Management LLC with notifications on news.